The global Primary Care POC Diagnostics Market was valued at USD 7.3 billion in 2020 and is projected to grow at a CAGR of 3.4% during the forecast period. The market growth is primarily driven by the shift in diagnostics from centralized labs to practitioners' offices, leading to increased usage of POC diagnostics in primary care settings. These devices offer ease-of-use in out-of-hospital laboratory settings, contributing to their growing adoption.
The importance of primary care in promoting health and achieving equitable distribution of healthcare has been increasingly recognized. Advances in POC diagnostics have been made possible by continuous developments in biosensors, microfluidics, bioanalytical platforms, assay formats, lab-on-a-chip technologies, and complementary technologies. The integration of POC testing with primary care providers has been found to be effective, further driving the growth of the primary care POC diagnostics market.
Get a free sample PDF of the report, visit @ https://www.reportsanddata.com/download-free-sample/4097
Efficiency enhancement and financial benefits are key factors driving the market growth of POC diagnostics in primary care. POC testing enables quick triage and treatment decisions, allowing clinicians to focus on providing high-quality patient care. Recent technological advancements have significantly improved the capabilities of POC diagnostic systems, including wireless reporting to electronic medical records for review by physicians. These devices also help increase efficiency, simplify processes, comply with regulations, and reduce staff pressure, thereby improving healthcare delivery. The combination of primary care and efficient POC diagnostics holds great potential for improving healthcare outcomes and driving market growth.
Apart from the benefits to medical personnel and patients, the introduction of POC diagnostic platforms can also yield financial benefits. By increasing efficiency and reducing specimen packaging and transportation time, the overall cost of treatment can be reduced. POC testing offers greater cost savings compared to core laboratory testing, leading to 8-20% savings in laboratory costs. The reduced waiting time for results can result in savings of up to USD 260 per patient and up to 46 minutes per patient. These cost and time savings are expected to further contribute to the growth of the primary care POC diagnostics market.
However, one of the key challenges restraining market growth is the stringent approval process for POCT devices. Manufacturers must demonstrate that healthcare professionals and patients can use these devices and obtain results similar to clinical laboratory tests. This rigorous process poses difficulties for the growth of the primary care POC diagnostics market.
In terms of product segmentation, glucose testing accounted for the largest market share in 2020. Self-testing glucose devices play a crucial role in monitoring glycemic levels for diabetic patients, leading to improved health outcomes. The increasing adoption of glucose monitoring devices, expanding diabetic population, and growing awareness of glucose level management are driving the revenue growth of this segment in the primary care POC diagnostics market.
Among the end-use segments, physician's offices accounted for the largest revenue share in 2020. This can be attributed to the rising demand for lateral flow assays in developing countries and a shift in customer preferences toward less stressful and time-consuming tests. The pharmacy and retail clinics segment is expected to be the fastest-growing segment due to the increasing number of patients requiring chronic disease tests at pharmacies and the availability of point-of-care testing at these facilities.
To know more about the latest insights of the report, visit @
https://www.reportsanddata.com/request-latest-insight/4097
Geographically, the North America market is expected to grow at a significant rate due to the presence of major market players in the region and the emphasis on patient involvement campaigns by healthcare organizations. The implementation of healthcare information systems, such as electronic health records (EHR), has improved the adoption rates of POCT in Europe, driving market growth. In Asia Pacific, government initiatives in various countries to improve access to primary care and integrate POC diagnostics into primary care settings contribute to the region's considerable revenue share.
Prominent players in the primary care POC diagnostics market include Roche Diagnostics, BD Biosciences, Danaher Corporation, Abbott Laboratories, Instrumentation Laboratory, bioMerieux, Siemens Healthcare, and Quidel Corporation. These companies are engaged in collaborations, business contracts, mergers and acquisitions, and joint ventures to strengthen their market position.
In conclusion, the primary care POC diagnostics market is witnessing growth driven by the shift toward decentralized diagnostics, efficiency enhancement, financial benefits, and technological advancements. Despite challenges in the approval process, the market is expected to expand with the increasing adoption of POC testing in primary care settings. The glucose testing segment holds a significant market share, while physician's offices and pharmacy/retail clinics are the key end-use segments. North America, Europe, and Asia Pacific are the major regions contributing to market growth.
Request a customized copy of the report @ https://www.reportsanddata.com/request-customization-form/4097
Thank you for reading our report. To inquire about customization or any query about the report, please get in touch with us. Our team will make sure the report is best suited to your needs.
Browse for more reports:
Seborrheic Dermatitis Treatment Market
Proteus Syndrome Treatment Market
Social Anxiety Disorder Market
Head and Neck Squamous Cell Carcinoma Treatment Market
About Reports and Data
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients to make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Products, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.
Contact Us:
John W
(Head of Business Development)
Reports and Data | Web: www.reportsanddata.com
Direct Line: +1-212-710-1370
E-mail: sales@reportsanddata.com
Blogs | Press Release | Industry News | Our competencies
Browse More Upcoming Reports @ https://www.reportsanddata.com/upcoming-reports
Browse More Latest Reports @ https://www.reportsanddata.com/report